When considering cost per pound of weight loss (factoring in effectiveness), semaglutide typically provides better value despite similar monthly costs
Site of gastrointestinal absorption of stabilized GLP-1RA peptides in dogs Fasted male beagle dogs weighing 68 kg were pretreated with pentagastrin 6 g/kg
Its long-acting formula helps regulate hunger and improve blood sugar control, making it a strong option for managing obesity
Assuming Eli Lilly follows a similar timeline to tirzepatide, the earliest possible FDA approval for retatrutide would likely occur in late 2027 or 2028, depending on Phase 3 trial results and regulatory review timelines

HOW TO IMPROVE RESULTS & REDUCE SYMPTOMS To maximize effectiveness and minimize common side effects, small lifestyle and recovery adjustments can make a meaningful difference: Prioritize protein intake to support satiety, muscle preservation, and metabolic health Stay well hydrated, especially during dose adjustments, to support digestion and detox pathways Build and preserve lean muscle through resistance training or strength-based movement Increase daily physical activity to enhance insulin sensitivity and fat metabolism Optimize sleep to regulate hunger hormones and support recovery Stack supportive MATTR modalities, such as Lymphatic Drainage to aid detoxification, ARRC Elysium Light Bed to boost immune function, Cryotherapy for inflammation and fat activation, HBOT for cellular recovery, and CVAC to enhance circulation, oxygen utilization and metabolic conditioning These strategies help create a more supportive internal environment, allowing GLP-1 and GIP therapies to work more effectively while promoting sustainable, long-term body recomposition and metabolic health
